Open AccessRecent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview
Author(s) -
A. I. Tabar,
J. Delgado,
E González-Mancebo,
E. Arroabarren,
Lorena Soto Retes,
Javier DomínguezOrtega,
Spanish Allergy
Publication year - 2021
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000513811
Subject(s) - asthma , medicine , allergy , allergen immunotherapy , immunotherapy , allergic asthma , intensive care medicine , immunology , allergen , adverse effect , immune system
The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.